| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |